Maximum Recommended Daily Dose of Micronized Progesterone
The maximum recommended dose of micronized progesterone is 200 mg daily for oral or vaginal administration when used for sequential endometrial protection in hormone replacement therapy, and up to 400 mg daily for oral administration in specific indications such as secondary amenorrhea. 1, 2
Dosing by Clinical Indication
For Hormone Replacement Therapy (Endometrial Protection)
Sequential Regimens:
- Oral micronized progesterone (MP): 200 mg daily for 12-14 days per month 1, 2
- Vaginal MP: 200 mg daily for 12-14 days per month 1
Continuous Regimens:
- Oral MP: 100 mg daily (continuous administration) 2
- This lower continuous dose provides adequate endometrial protection when given without interruption
The 2021 Blood Reviews guideline specifically states that sequential regimens require 200 mg of oral or vaginal MP for 12-14 days every 28 days when combined with transdermal estradiol 1. The 2011 AACE guidelines similarly recommend either 100 mg daily or 200 mg for 10-12 days per month 2.
For Secondary Amenorrhea
Higher doses are used for this indication:
- Oral MP: 300-400 mg daily for 10 days 3
The FDA drug label documents that studies used 300 mg per day (resulting in 73.8% withdrawal bleeding) and 400 mg per day (resulting in 76.8% withdrawal bleeding) in premenopausal women with secondary amenorrhea 3. The 400 mg dose induced complete secretory changes in 45% of estrogen-primed postmenopausal women 3.
Important Dosing Considerations
Route-specific bioavailability matters: Oral micronized progesterone has lower bioavailability due to first-pass hepatic metabolism compared to vaginal administration 3. However, the vaginal route achieves higher local endometrial concentrations with lower systemic exposure.
Exceeding 200 mg per intake is not advisable for threatened miscarriage or preventing recurrent miscarriage due to luteal phase insufficiency, according to recent Thai recommendations 4.
The 2016 ESHRE guideline for premature ovarian insufficiency recommends oral micronized progesterone at 100-200 mg/day or dydrogesterone 5-10 mg/day during 12-14 days of the month for cyclic progestogen therapy 5.
Safety Profile at Maximum Doses
The FDA label indicates that doses up to 400 mg daily have been studied in clinical trials without major safety concerns beyond typical progesterone side effects (drowsiness, dizziness) 3. The pharmacokinetics appear linear and dose-proportional from 100-400 mg daily 3.
Common pitfall: Do not confuse micronized progesterone dosing with synthetic progestins (like medroxyprogesterone acetate at 2.5-10 mg daily), which have different potencies and dosing schedules 2.